No Result
View All Result
SUBSCRIBE | NO FEES, NO PAYWALLS
MANAGE MY SUBSCRIPTION
NEWSLETTER
Corporate Compliance Insights
  • Home
  • About
    • About CCI
    • CCI Magazine
    • Writing for CCI
    • Career Connection
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Explore Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Well-Being at Work
    • Leadership and Career
    • Opinion
  • Vendor News
  • Library
    • Download Whitepapers & Reports
    • Download eBooks
    • New: Living Your Best Compliance Life by Mary Shirley
    • New: Ethics and Compliance for Humans by Adam Balfour
    • 2021: Raise Your Game, Not Your Voice by Lentini-Walker & Tschida
    • CCI Press & Compliance Bookshelf
  • Podcasts
    • Great Women in Compliance
    • Unless: The Podcast (Hemma Lomax)
  • Research
  • Webinars
  • Events
  • Subscribe
Jump to a Section
  • At the Office
    • Ethics
    • HR Compliance
    • Leadership & Career
    • Well-Being at Work
  • Compliance & Risk
    • Compliance
    • FCPA
    • Fraud
    • Risk
  • Finserv & Audit
    • Financial Services
    • Internal Audit
  • Governance
    • ESG
    • Getting Governance Right
  • Infosec
    • Cybersecurity
    • Data Privacy
  • Opinion
    • Adam Balfour
    • Jim DeLoach
    • Mary Shirley
    • Yan Tougas
No Result
View All Result
Corporate Compliance Insights
Home Compliance

COVID-19 and Antitrust: Government Announcements and Recommendations

The Impact of the DOJ’s New Directive

by David Reichenberg
March 30, 2020
in Compliance, Featured
stack of cash beside stack of medical masks

As health care and cleaning products fly off the shelves, the DOJ is taking action. Cozen O’Connor’s David Reichenberg discusses how its new directive is affecting everyday business and what organizations can do to maintain compliance.

In the wake of this global pandemic, competition law and associated compliance are likely not the first topics that come to people’s minds. Nonetheless, there have been a series of government announcements from federal and state officials that address important economic phenomena that bear upon our ability to get through this crisis. This article quickly reviews those government announcements, discusses certain private party reactions and potential scenarios and makes recommendations on how compliance professionals and stakeholders may consider forging a path forward.

Government Announcements – What’s Happened

On March 9, 2020, the Department of Justice (including its Antitrust Division) published a press release cautioning the public that collusive practices between competitors such as price fixing and market allocation will still be prosecuted criminally, including for products and services essential to combating the crisis. Also on March 9, the Federal Trade Commission announced that it had sent warning letters to certain companies for misleading or fraudulent practices that sought to capitalize on the public’s fears. Both agencies said they would monitor social media, online marketplaces and incoming complaints to initiate investigations and bring necessary actions. The DOJ will continue to use its Procurement Collusion Strike Force to identify patterns and suspicious behavior.[1]

Governors and State Attorney General Offices, such as those from California, Michigan, Massachusetts and New York, have also made announcements targeting price gouging on essential goods and sent cease-and-desist letters to companies following up on private complaints. Several AG offices have setup new hotlines and email addresses to receive feedback specific to COVID-19.

In addition, on March 24, 2020, the DOJ and FTC released joint guidance relating to potential collaborations between competitors to combat the crisis. The guidance gave examples of collaborations that likely do not violate the antitrust laws, such as health care facilities working together to provide resources and services to communities without immediate access to personal protective equipment, medical supplies or health care. The FTC and DOJ committed to provide responses within seven days to companies that solicit their input on specific matters. Still, the notice reiterated that the agencies stand ready to pursue criminal and civil violations of the antitrust laws, including restraints on competition that increase prices, lower wages or decrease output and efforts by monopolists to engage in exclusionary conduct. While the guidance did not identify such civil misconduct specifically, they may include vertical distribution or pricing practices that are argued to hinder the availability of products.

Corporate Responses to COVID-19 Antitrust Announcements – Initial Reactions and Potential Scenarios

In many cases, there is an obvious need and opportunity for companies to engage with customers and prospective customers through this crisis, for many reasons broader than antitrust. Still, there are examples of such efforts that implicitly address the concerns raised by the authorities, including: (1) converting manufacturing capacity from traditionally produced products to essential crisis products such as antibacterial soap, (2) setting aside funds to support logistical efforts for treatment, (3) combining research efforts to determine how the immune system responds to the virus, (4) adapting medical production facilities to increase the output of ventilators and (5) designers’ use of sewing teams to make medical masks and hospital gowns.

All of these efforts illustrate corporate cultures that embrace being a part of the solution, rather than an alleged “opportunist” that seeks to benefit from fear, uncertainty and doubt resulting from the pandemic. In the best cases, companies’ efforts are providing supply in areas where it is needed most, and thus traditionally, would lower prices to consumers. While application of antitrust laws does not usually depend upon a party’s intent, under these circumstances, an effective crisis management strategy and action plan may lessen the likelihood that an authority has reason to scrutinize other practices.

The aforementioned antitrust scrutiny of companies that sell essential goods to those retailers is an area in which corporate responses are in potentially challenging and unprecedented waters. For instance, demand may greatly outpace supply for essential products, and companies need to set out supply, distribution and pricing plans that can draw scrutiny from customers and/or authorities. In such circumstances, may the company reach out to its competitor to assess whether an alternative joint production plan can meet a customer’s concerns? While the most recent joint guidance suggests that such collaboration may be permitted, there may still be a concern that the companies cannot provide specific capacity details or other confidential information to accomplish an important public service (which an antitrust lawyer may call a paramount “procompetitive effect” or “efficiency”).

As another example, what if a company has fallen on hard times in the wake of the crisis and is in serious danger of going out of business, but can be acquired by a market leader that has the financial ability to weather the storm and maintain product lines that consumers want outside of a pandemic? In this circumstance, under current joint guidance (see earlier footnote), the government may seek extra time to review the deal. Traditionally, such “failing firm” or “efficiency-based” defenses do not pass muster, but perhaps the situation could be different in these circumstances warranting a different result.

Recommendations – How Should We Proceed?

Make Certain You and Your Company are Doing Your Part

As the above examples illustrate, there may be low-hanging fruit in terms of actions your company can take that both accomplish its overall objectives and address the concerns expressed by the antitrust authorities. If your company has the ability to lend its resources or convert its capabilities to an initiative that is most needed or can aid the government’s ability to tackle the pandemic (e.g., through messaging advocating safety), that would bode well for the antitrust effort.  Again, while these efforts may not necessarily address the phenomena antitrust is most concerned with (e.g., price, supply, innovation, choice), it is a point in the right direction.

Aim for Open Dialogue with Regulators and Customers

The foregoing guidance issued by regulators should be heeded by companies as they assess their reaction and strategy in response to the crisis. At the same time, where companies are considering actions that do not neatly fit into one of the expressly addressed scenarios, it would be incredibly helpful to have a constructive dialogue with regulators or concerned customers about a way forward that accomplishes everyone’s objectives. While the opportunity to submit a business review letter may prove effective in certain situations, there may be decisions that cannot wait seven days for feedback, and it would be more productive to engage in real-time discussion. One key to such a dialogue is for both parties not to fear that that the other party is waiting for a “gotcha” moment, which leads to an investigation or complaint on the agency side or an argued concession/waiver on either side. In this environment, parties likely seek to do the right thing and not take advantage of the situation; creating a process or dialogue for that to happen openly appears most productive.

Take the Opportunity to Create/Refresh/Recirculate Your Antitrust Compliance Program

The topline takeaway from the first DOJ/FTC announcement is that antitrust law still applies, despite unprecedented circumstances, where companies and individuals need to do their part to be sure that compliance occurs. If your company does not have an antitrust compliance policy, program and/or associated training, this is an opportune time to implement one. If your company has a program in place, but it has not been updated recently or there are new scenarios that can be reasonably expected in this environment, it is also a good time to refresh and/or recirculate.

While antitrust is probably not the first thing on people’s minds right now, its aims and objectives are in line with getting to the other side of this crisis most quickly, productively and cooperatively.


[1] In addition, on March 13, 2020, the DOJ Antitrust Division and FTC announced a series of temporary changes to their merger review process during the pendency of the pandemic.  These include: the suspension of early termination (in which a deal is cleared within 30 days), a request by the DOJ Antitrust Division that merging parties give it an additional 30 days to complete its review of transactions, and acceptance only of electronic filings. On March 27, the agencies announced that they would resume the practice of granting early terminations when it is determined that no enforcement actions would be taken.


Tags: AntitrustCOVID-19
Previous Post

3 (More) Considerations to Weather Transformation

Next Post

Principled

David Reichenberg

David Reichenberg

David Reichenberg is an Antitrust and Litigation Partner at Cozen O’Connor in New York, and has advised leading Fortune 500 companies as well as start-ups on the full range of competition issues arising out of counseling, litigation and mergers and acquisitions.

Related Posts

tracking prices

Pricing Algorithms Raise New Antitrust Concerns

by FTI Consulting
May 13, 2025

Interdisciplinary frameworks can help manage legal, privacy and consumer protection risks

california state flag and us flag

How California’s AG Will Shape Enforcement Landscape in 2025

by Carrie H. Cohen, Christine Y. Wong, Brian R. Michael and C.B. Rome
March 4, 2025

Golden State's enforcement agenda targets fossil fuel industry, merger challenges and AI regulation

political figurines meeting on top of US map

Beyond the Beltway: State AGs Could Chart Bold Enforcement Course

by Matthew P. Diehr, Rebecca Furdek, Julia Banegas and Abraham J. Souza
February 12, 2025

A dramatic shift in federal leadership has heightened attention on state attorneys general offices, which have long served as powerful...

new yorkers in covid masks on street

Covid Fraud Enforcement (Yes, This Is Still a Thing)

by Denise M. Barnes and Brian Irving
February 7, 2025

With $2B recovered and $36B in estimated fraud, DOJ signals years of continued pandemic relief investigations ahead

Next Post
principled featured

Principled

No Result
View All Result

Privacy Policy | AI Policy

Founded in 2010, CCI is the web’s premier global independent news source for compliance, ethics, risk and information security. 

Got a news tip? Get in touch. Want a weekly round-up in your inbox? Sign up for free. No subscription fees, no paywalls. 

Follow Us

Browse Topics:

  • CCI Press
  • Compliance
  • Compliance Podcasts
  • Cybersecurity
  • Data Privacy
  • eBooks Published by CCI
  • Ethics
  • FCPA
  • Featured
  • Financial Services
  • Fraud
  • Governance
  • GRC Vendor News
  • HR Compliance
  • Internal Audit
  • Leadership and Career
  • On Demand Webinars
  • Opinion
  • Research
  • Resource Library
  • Risk
  • Uncategorized
  • Videos
  • Webinars
  • Well-Being
  • Whitepapers

© 2025 Corporate Compliance Insights

Welcome to CCI. This site uses cookies. Please click OK to accept. Privacy Policy
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
No Result
View All Result
  • Home
  • About
    • About CCI
    • CCI Magazine
    • Writing for CCI
    • Career Connection
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Explore Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Well-Being at Work
    • Leadership and Career
    • Opinion
  • Vendor News
  • Library
    • Download Whitepapers & Reports
    • Download eBooks
    • New: Living Your Best Compliance Life by Mary Shirley
    • New: Ethics and Compliance for Humans by Adam Balfour
    • 2021: Raise Your Game, Not Your Voice by Lentini-Walker & Tschida
    • CCI Press & Compliance Bookshelf
  • Podcasts
    • Great Women in Compliance
    • Unless: The Podcast (Hemma Lomax)
  • Research
  • Webinars
  • Events
  • Subscribe

© 2025 Corporate Compliance Insights